Trial NCT02761694

View at ClinicalTrials.gov 
Org. Study IDs: 4440-001
Secondary IDs: ARQ 751-101 MK-4440-001

Last trial update was posted on 2023-05-06

MeSH Interventions

Fulvestrant Paclitaxel

MeSH Conditions

Neoplasms

Other Conditions

Cancer Solid Tumors

Stopping Reasons

Business Reasons

Limitations And Caveats

N/A

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID